SERA Prognostics CEO Lindgardt Zhenya sold 20,139 shares at $2 per share on September 8, 2026. For investors, the transaction leaves Zhenya with 844,870 shares, while the sale represents about 2.3% of the executive’s prior shareholding, according to the reported transaction details.
Key Highlights
- Lindgardt Zhenya held 844,870 SERA Prognostics shares after the transaction.
- The sale represented about 2.3% of the chief executive’s prior shareholding.
- Transaction code S classified the disposal as an open-market sale on September 8, 2026.
SERA PROGNOSTICS, INC. (NASDAQ: SERA) shares held by Chief Executive Officer Lindgardt Zhenya fell by 20,139 at a transaction price of $2 per share. The sale took place on September 8, 2026. The reported sale price was $2 per share.
Post-Transaction Ownership
and Sale Size Zhenya’s reported ownership after the transaction stood at 844,870 shares. The transaction represented about 2.3% of Zhenya’s prior shareholding in SERA PROGNOSTICS, INC. The ownership figure and percentage are the stated post-transaction and prior-holding measures for the chief executive’s shares.
FAQs
Q: How many SERA Prognostics shares did Lindgardt Zhenya sell?
A: Lindgardt Zhenya sold 20,139 SERA Prognostics shares. The transaction price was $2 per share, and the sale occurred on September 8, 2026.
Q: What was the impact of the SERA Prognostics CEO share sale?
A: Lindgardt Zhenya’s reported ownership after the transaction was 844,870 shares. The sale represented about 2.3% of the executive’s prior shareholding.
Q: Was the SERA Prognostics transaction an open-market sale?
A: It reports that CEO Lindgardt Zhenya sold 20,139 shares at $2 per share on September 8, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.